For the past 20 years, I have worked on the clinical and commercial development of global pharmaceutical brands, being responsible for the strategic development of pre-launch clinical plans and global launch communication "roadmaps" as well as domestic post-launch tactical implementation. A consultant pharmacist by training, I specialize in the integration of clinical data with global marketing strategy, forging a vital link in the commercialization of global brands. Through the analysis of current market forces and physician prescribing habits, I aim to create global strategic communication plans that ensure the timely dissemination of clinical data in line with long-term commercial goals.Through my clinical and post-graduate training, I focus on developing global marketing & educational platforms that utilize key thought leaders, prescribers, and the patient in various group and one-on-one initiatives. Interacting with a variety of health care professionals, my clinical training and team training skills are utilized to develop strategies to influence physicians and health care administrators to implement more efficient and effective treatment plans. With postdoctoral training in public health, I maintain a strong focus in primary health promotion and non-traditional learning and marketing strategies, utilizing clinical data to influence key influencers and primary physicians alike.Specialties: I have worked extensively in the field of Alzheimer’s Disease for the past 12 years on 3 commercial compounds as well as 6 investigational compounds. Other areas of interest in the CNS field include Parkinson’s Disease, Multiple Sclerosis, Amyotrophic Lateral Sclerosis, Chronic & Acute Pain, Schizophrenia, and Depression. I have also worked on a number of oncology compounds, including compounds for brain metastases, metastatic breast cancer, MDS, CML, and Multiple Myeloma